We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUY
751
DELISTED
Yamana Gold, Inc.
AUY
$73K ﹤0.01%
12,940
-4,650
-26% -$27.9K
CVE icon
752
Cenovus Energy
CVE
$56.5B
$72K ﹤0.01%
18,527
BSBR icon
753
Santander
BSBR
$37.8B
$59K ﹤0.01%
12,444
OXY.WS icon
754
CALL
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$44K ﹤0.01%
+1,473,200
New +$4.71M
GPL
755
DELISTED
Great Panther Mining Limited
GPL
$12K ﹤0.01%
+1,400
New +$12.1K
MDT icon
756
Medtronic
MDT
$110B
$5K ﹤0.01%
44
+18
+69% +$1.81K
TM icon
757
Toyota
TM
$227B
$5K ﹤0.01%
41
+1
+3% +$130
APTV icon
758
Aptiv
APTV
$12.3B
$4K ﹤0.01%
39
+9
+30% +$755
BHP icon
759
BHP
BHP
$218B
$4K ﹤0.01%
82
+6
+8% +$289
TEL icon
760
TE Connectivity
TEL
$59.9B
$4K ﹤0.01%
36
-25
-41% -$2.3K
HMC icon
761
Honda
HMC
$39.9B
$3K ﹤0.01%
115
+1
+0.9% +$25
TT icon
762
Trane Technologies
TT
$97.3B
$3K ﹤0.01%
22
-2
-8% -$225
ACN icon
763
Accenture
ACN
$99.9B
$2K ﹤0.01%
7
ETN icon
764
Eaton
ETN
$150B
$2K ﹤0.01%
20
-2
-9% -$196
HSBC icon
765
HSBC
HSBC
$367B
$2K ﹤0.01%
108
+67
+163% +$1.47K
NVO
766
Novo Nordisk
NVO
$228B
$2K ﹤0.01%
44
-49,162
-100% -$1.64M
TEF
767
DELISTED
Telefonica
TEF
$2K ﹤0.01%
745
+134
+22% +$472
WBK
768
DELISTED
Westpac Banking Corporation
WBK
$2K ﹤0.01%
185
+92
+99% +$1.14K
CRH icon
769
CRH
CRH
$64.1B
$1K ﹤0.01%
38
-28
-42% -$1.05K
EQNR icon
770
Equinor
EQNR
$96.8B
$1K ﹤0.01%
82
+5
+6% +$77
GSK icon
771
GSK
GSK
$104B
$1K ﹤0.01%
14
ING icon
772
ING
ING
$99.8B
$1K ﹤0.01%
+80
New +$611
NVCR icon
773
NovoCure
NVCR
$1.77B
$1K ﹤0.01%
10
+1
+11% +$80
VOD icon
774
Vodafone
VOD
$37.2B
$1K ﹤0.01%
41
+5
+14% +$75
CAJ
775
DELISTED
Canon, Inc.
CAJ
$1K ﹤0.01%
50
-20,452
-100% -$363K

Similar funds

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.